Meta-Analysis Finds Benefit for Dual Antiplatelet Therapy but Limitations Preclude Changing Standard Mono Antiplatelet Therapy Approach for Acute Non-Cardioembolic Ischaemic Stroke or Transient Ischaemic Attack

Authors

Wilbert S. Aronow, New York Medical CollegeFollow

Author Type(s)

Faculty

DOI

10.1136/eb-2013-101649

Journal Title

Evidence-Based Medicine

First Page

94

Last Page

94

Document Type

Article

Publication Date

6-1-2014

Department

Medicine

Keywords

Brain Ischemia, Humans, Ischemic Attack, Transient, Platelet Aggregation Inhibitors

Disciplines

Medicine and Health Sciences

Recommended Citation

Aronow, W. S. (2014). Meta-Analysis Finds Benefit for Dual Antiplatelet Therapy but Limitations Preclude Changing Standard Mono Antiplatelet Therapy Approach for Acute Non-Cardioembolic Ischaemic Stroke or Transient Ischaemic Attack. Evidence-Based Medicine, 19 (3), 94-94. https://doi.org/10.1136/eb-2013-101649